Pimozide as a replacement for maintenance therapy in chronic schizophrenia

Area of Science:

• Psychiatry
• Clinical Pharmacology

Background:

• Schizophrenia treatment often involves antipsychotic maintenance therapy.
• Some patients exhibit poor response to conventional neuroleptic monotherapy or polytherapy.

Purpose of the Study:

• To investigate pimozide as a replacement for antipsychotic maintenance therapy in chronic schizophrenia.
• To assess the efficacy and long-term effectiveness of pimozide in non-responsive patients.

Main Methods:

• An open-label, 12-week study.
• 30 patients with chronic schizophrenia received pimozide (12 mg daily).
• Patients had previously shown poor response to other antipsychotic treatments.

Main Results:

• Significant improvement in 18 Brief Psychiatric Rating Scale symptoms after 8 weeks of pimozide treatment.
• Statistically significant improvements noted in conceptual disorganization, depressive mood, hostility, and motor retardation.
• Eleven patients continued pimozide monotherapy for 1 year, maintaining or improving their functioning.

Conclusions:

• Pimozide serves as an effective alternative for antipsychotic maintenance therapy in select chronic schizophrenia patients.
• Pimozide demonstrates sustained efficacy and functional improvement in patients with inadequate response to prior treatments.